SCHEMBL23155169

SCHEMBL23155169

c1ccc2c(c1)-c1cccc3c1-c1cc(N(c4ccc5c(c4)oc4ccccc45)c4cccc5ccccc45)ccc1-c1cccc-3c1-2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DUSP3 P51452 1/20 0.36
▸ AHR P35869 2/20 0.35
▸ MAPT P10636 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ GAA P10253 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ NTRK1 P04629 1/20 0.32
▸ PLK3 Q9H4B4 1/20 0.32
▸ DNMT1 P26358 1/20 0.32
▸ PSD A5PKW4 1/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ MAOA P21397 1/20 0.30
▸ RAB9A P51151 2/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155167 0.93 MAPT (0.35) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL23155358 0.88 L3MBTL1 (0.33) ALDH1A1HPGDALOX5DNMT1L3MBTL1
SCHEMBL17637178 0.87 AHR (0.45) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL23155359 0.87 ALOX5 (0.40) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL23155227 0.87 MEN1 (0.35) AHRMAPTKMT2AKDM4EALDH1A1
SCHEMBL23155244 0.87 AHR (0.36) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL25580575 0.85 DUSP3 (0.34) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL23155362 0.85 AHR (0.39) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL24472503 0.85 AHR (0.41) DUSP3AHRMAPTKMT2AKDM4E
SCHEMBL23155156 0.85 DNMT1 (0.40) MAPTKMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 DUSP3 4843/4885AHR 1479/4885MAPT 4116/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 DUSP3 4843/4885AHR 1479/4885MAPT 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback